Abstract

Intra-atrial-reentrant-tachycardia (IART) is a common source of morbidity in adults with congenital heart disease (ACHD). Most patients (pts) that present with IART are treated with direct current cardioversion (DCCV). There is limited data on the efficacy of intravenous (IV) anti-arrhythmics for acute conversion of IART in the ACHD population.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call